Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

January 2020; 7 (1) Clinical/Scientific NotesOpen Access

An inflammatory milieu

Optic perineuritis, retroperitoneal fibrosis, and giant cell arteritis

Doria M. Gold, Steven L. Galetta
First published November 26, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000642
Doria M. Gold
From the Department of Neurology (D.M.G.) and Departments of Neurology and Ophthalmology (S.L.G.), NYU Langone Medical Center, New York.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven L. Galetta
From the Department of Neurology (D.M.G.) and Departments of Neurology and Ophthalmology (S.L.G.), NYU Langone Medical Center, New York.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
An inflammatory milieu
Optic perineuritis, retroperitoneal fibrosis, and giant cell arteritis
Doria M. Gold, Steven L. Galetta
Neurol Neuroimmunol Neuroinflamm Jan 2020, 7 (1) e642; DOI: 10.1212/NXI.0000000000000642

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
571

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Case summary

Optic nerve perineuritis targets the optic nerve sheath; it is idiopathic or a manifestation of systemic inflammatory diseases such as myelin oligodendrocyte glycoprotein (MOG) antibody syndrome, sarcoidosis, granulomatosis with polyangiitis, IgG4-related disease, or giant cell arteritis (GCA).1 Radiographically, there is optic nerve sheath enhancement and, occasionally, orbital fat “streaking.”1 Biopsies have identified dural sheath lymphocytic infiltrate, perineural fibrous tissue, granulomas, or evidence of small-vessel vasculitis.1 Retroperitoneal fibrosis (RPF) is defined by abdominal organ fibrosis. Usually idiopathic, it may be secondary to medication, radiation, or systemic inflammatory conditions.2 Pathologically, its hallmark is fibrosis and infiltration of macrophages, B-lymphocytes, and T-lymphocytes.2 Often considered when older patients present with headache or ischemic optic neuropathy, GCA is the most common large-vessel vasculitis.3 It has been proposed that GCA results from a T-cell-mediated inflammatory cascade, causing vascular intimal hyperplasia.3 GCA has rarely been reported in association with RPF4,5 or perineuritis.6,7 We present a patient initially diagnosed with idiopathic RPF treated with immunosuppression, who subsequently developed optic perineuritis followed by GCA.

A 71-year-old man presented to the emergency department with urosepsis and renal insufficiency. He was treated with intravenous (IV) antibiotics for positive urine and blood cultures, but his kidney function remained abnormal. Renal ultrasound revealed bilateral hydronephrosis, and MRI abdomen/pelvis showed a retroperitoneal mass. Biopsy demonstrated patchy fibrosis and soft tissue lymphoplasmacytic infiltrate. IgG antibody staining was negative. He was treated with mycophenolate for 2 years.

Six years later, he presented for having had 5 days of left eye vision loss that remained stable from onset. He endorsed jaw soreness but denied diplopia. Acuity was 20/25 in each eye. He had a trace left afferent pupillary defect, and color plates were performed more slowly on the left. Optic discs were without swelling or pallor. He had normal ocular motility. Humphrey visual fields revealed few nonspecific points of depression in each eye and an inferonasal defect in the left eye that corresponded with his complaint. He had no temporal artery thickening or tenderness. He was sent to the emergency department for blood work and IV steroids for presumed GCA. Erythrocyte sedimentation rate (20 mm/h) and platelets (281,000/mm3) were in the normal range, and C-reactive protein was mildly elevated (13 mg/L). IV methylprednisolone was initiated. Chest X-ray was normal. MRI/magnetic resonance angiography of the brain demonstrated mild microvascular ischemic changes and volume loss with normal vasculature. Orbital MRI showed optic nerve sheath enhancement and orbital fat stranding (figure, A and C).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure MRI orbits

Coronal (A) and axial (C) MRI orbits at initial presentation demonstrating optic perineuritis (red arrows) and fat stranding (blue arrowheads) left greater than the right. Axial MRI orbits after 6 months demonstrating bilateral thickening and enhancement of the ophthalmic arteries (blue arrows) and improved optic perineuritis (red arrows) (B and D).

Laboratory workup revealed elevated HgA1c (7.9%), serum glucose (239 mg/dL), and subclinical hypothyroidism (thyroid stimulating hormone 5.980 mIU/L). In addition, there were negative Lyme titers, serum paraneoplastic panel, aquaporin-4 receptor, MOG, and antineutrophil cytoplasmic antibodies. Serum IgG4 levels were not elevated. CSF examination showed red blood cells 3, white blood cells 3, elevated protein (74 mg/dL), elevated glucose (144 mg/dL), negative cytology, flow cytometry, culture, venereal disease research laboratory test (to evaluate for syphilis), and Lyme antibodies. Serum immunoglobulins, CSF IgG index, and oligoclonal bands were not checked.

Corticosteroids were tapered over 5 months. One month after complete discontinuation, he endorsed a new left temporal headache. He denied visual symptoms, jaw claudication, or muscle weakness. Examination was improved with acuity 20/20 OU. Repeat MRI brain/orbits revealed bilateral ophthalmic and superficial temporal artery thickening and enhancement, compatible with GCA. There was near-complete resolution of the left optic perineural enhancement (figure, B and D). Temporal artery biopsy confirmed the diagnosis with lymphocytes, macrophages, granulomatous inflammation, and no IgG4-positive cells. High-dose oral prednisone (1 mg/kg) treatment was initiated and followed by a slow taper, which maintained resolution of headaches. Repeat imaging showed decreased ophthalmic and temporal artery enhancement and resolved optic nerve sheath inflammation. There was no aortic involvement on MRA chest.

Our patient manifested with 3 sequential inflammatory disorders: RPF, optic perineuritis, and GCA. Clinically, each was mild. Although an umbrella of GCA-related vasculitis may be suggested, his course supports a less specific systemic inflammatory process uniquely expressed at 3 different time points. Although the exact pathogenesis of perineuritis, RPF, and GCA typically do not overlap, each condition results from cell-mediated immunologic overactivation, resulting in fibrosis and granulomatous inflammation.

In the few reported cases of perineuritis and GCA, most had bilateral perineural involvement on neuroimaging. In addition, examination often demonstrated optic neuropathy or ocular motility impairment.6,7 Unlike our patient who rapidly responded to steroids, the optic nerve dysfunction typically did not improve. In the cases of RPF described with GCA, patients had a more fulminant presentation. Perhaps our patient's immunosuppression for RPF with mycophenolate, which suppresses B-lymphocyte and T-lymphocyte proliferation, dampened the later cell-mediated response. Fortunately, our patient had an indolent course despite tissue and arterial inflammatory changes. To our knowledge, the conditions RPF, perineuritis, and GCA have not been documented in a single patient nor after prolonged immunosuppression.

Study funding

No targeted funding reported.

Disclosure

D.M. Gold and S.L. Galetta report no disclosures. Go to Neurology.org/NN for full disclosures.

Appendix Authors

Table

Footnotes

  • The Article Processing Charge was funded by the NYU Langone Medical Center Department of Neurology.

  • Go to Neurology.org/NN for full disclosures. Funding information is provided at the end of the article.

  • Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Purvin V,
    2. Kawasaki A,
    3. Jacobson DM
    . Optic perineuritis: clinical and radiographic features. Arch Ophthalmol 2001;119:1299–1306.
    OpenUrlPubMed
  2. 2.↵
    1. Vaglio A,
    2. Maritati F
    . Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol 2016;27:1880–1889.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Watanabe R,
    2. Goronzy JJ,
    3. Berry G,
    4. Liao YJ,
    5. Weyand CM
    . Giant cell arteritis: from pathogenesis to therapeutic management. Curr Treat Opt Rheumatol 2016;2:126–137.
    OpenUrl
  4. 4.↵
    1. Protopsaltis I,
    2. Sotiropoulos A,
    3. Foteinos A, et al
    . Chronic periaortitis (retroperitoneal fibrosis) concurrent with giant cell arteritis: a case report. J Med Case Rep 2014;8:167.
    OpenUrl
  5. 5.↵
    1. Tolle PA,
    2. Kesten F,
    3. Daikeler T
    . Giant cell arteritis followed by idiopathic retroperitoneal fibrosis in the same patient—an unexpected positron emission tomography finding. Rheumatology (Oxford) 2012;51:1549.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Pappolla A,
    2. Silveira F,
    3. Norscini J,
    4. Miquelini L,
    5. Patrucco L
    . Bilateral optic perineuritis as initial presentation of giant cell arteritis. Neurologist 2019;24:26–28.
    OpenUrl
  7. 7.↵
    1. Liu TY,
    2. Miller NR
    . Giant cell arteritis presenting as unilateral anterior ischemic optic neuropathy associated with bilateral optic nerve sheath enhancement on magnetic resonance imaging. J Neuroophthalmol 2015;35:360–363.
    OpenUrl

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case summary
    • Study funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology

Dr. Babak Hooshmand and Dr. David Smith

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Autoimmune diseases
  • MRI
  • Vasculitis
  • Secondary headache disorders
  • Visual loss

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis
    Maria A. Nagel, Jeffrey L. Bennett, Nelly Khmeleva et al.
    Neurology, May 01, 2013
  • Article
    Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis
    Don Gilden, Teresa White, Nelly Khmeleva et al.
    Neurology, February 18, 2015
  • Articles
    Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis
    J.C. Kattah, L. Mejico, G.A. Chrousos et al.
    Neurology, July 01, 1999
  • Brief Communications
    Refractory giant cell arteritis with spinal cord infarction
    S. L. Galetta, L. J. Balcer, A. P. Lieberman et al.
    Neurology, December 01, 1997
Neurology - Neuroimmunology Neuroinflammation: 10 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise